BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38164184)

  • 1. Targeting phosphorylation circuits on CREB and CRTCs as the strategy to prevent acquired skin hyperpigmentation.
    Kim SH; Na C; Yun CY; Kim JG; Baek ST; An HJ; Lee JD; Lee SW; Jung JK; Hwang BY; Han SB; Kim Y
    Int J Biol Sci; 2024; 20(1):312-330. PubMed ID: 38164184
    [No Abstract]   [Full Text] [Related]  

  • 2. Sargaquinoic acid ameliorates hyperpigmentation through cAMP and ERK-mediated downregulation of MITF in α-MSH-stimulated B16F10 cells.
    Azam MS; Kwon M; Choi J; Kim HR
    Biomed Pharmacother; 2018 Aug; 104():582-589. PubMed ID: 29803170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of melanogenesis by 3-(1'-methyltetrahydropyridinyl)-2,4-6-trihydroxy acetophenone via suppressing the activity of cAMP response element-binding protein (CREB) and nuclear exclusion of CREB-regulated transcription coactivator 1 (CRTC1).
    Naikoo SH; Rashid H; Kumar S; Archoo S; Sheikh UA; Lone NA; Singh PP; Tasduq SA
    Eur J Pharmacol; 2023 Aug; 952():175734. PubMed ID: 37080332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Viniferin Improves Facial Hyperpigmentation via Accelerating Feedback Termination of cAMP/PKA-Signaled Phosphorylation Circuit in Facultative Melanogenesis.
    Yun CY; Mi Ko S; Pyo Choi Y; Kim BJ; Lee J; Mun Kim J; Kim JY; Song JY; Kim SH; Hwang BY; Tae Hong J; Han SB; Kim Y
    Theranostics; 2018; 8(7):2031-2043. PubMed ID: 29556371
    [No Abstract]   [Full Text] [Related]  

  • 5. Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation.
    Yun CY; Roh E; Kim SH; Han J; Lee J; Jung DE; Kim GH; Jung SH; Cho WJ; Han SB; Kim Y
    Theranostics; 2020; 10(1):340-352. PubMed ID: 31903124
    [No Abstract]   [Full Text] [Related]  

  • 6. JNK suppresses melanogenesis by interfering with CREB-regulated transcription coactivator 3-dependent MITF expression.
    Kim JH; Hong AR; Kim YH; Yoo H; Kang SW; Chang SE; Song Y
    Theranostics; 2020; 10(9):4017-4029. PubMed ID: 32226536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.
    Yun CY; You ST; Kim JH; Chung JH; Han SB; Shin EY; Kim EG
    J Invest Dermatol; 2015 May; 135(5):1385-1394. PubMed ID: 25560280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression.
    Lee CS; Jang WH; Park M; Jung K; Baek HS; Joo YH; Park YH; Lim KM
    Exp Dermatol; 2013 Nov; 22(11):762-4. PubMed ID: 24107097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP-binding site of PKA as a molecular target of bisabolangelone against melanocyte-specific hyperpigmented disorder.
    Roh E; Yun CY; Young Yun J; Park D; Doo Kim N; Yeon Hwang B; Jung SH; Park SK; Kim YB; Han SB; Kim Y
    J Invest Dermatol; 2013 Apr; 133(4):1072-9. PubMed ID: 23254773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tribuloside acts on the PDE/cAMP/PKA pathway to enhance melanogenesis, melanocyte dendricity and melanosome transport.
    Cao Y; Lv J; Tan Y; Chen R; Jiang X; Meng D; Zou K; Pan M; Tang L
    J Ethnopharmacol; 2024 Apr; 323():117673. PubMed ID: 38158096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.
    Shin H; Hong SD; Roh E; Jung SH; Cho WJ; Park SH; Yoon DY; Ko SM; Hwang BY; Hong JT; Heo TY; Han SB; Kim Y
    Br J Pharmacol; 2015 Jul; 172(13):3434-45. PubMed ID: 25766244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphlorethohydroxycarmalol inhibits melanogenesis via protein kinase A/cAMP response element-binding protein and extracellular signal-regulated kinase-mediated microphthalmia-associated transcription factor downregulation in α-melanocyte stimulating hormone-stimulated B16F10 melanoma cells and zebrafish.
    Ding Y; Jiang Y; Im ST; Myung S; Kim HS; Lee SH
    Cell Biochem Funct; 2021 Jun; 39(4):546-554. PubMed ID: 33474761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inhibitory mechanism of action of a novel syringic-acid derivative on α-melanocyte-stimulating hormone (α-MSH)-induced melanogenesis.
    Jeong YJ; Lee JY; Park J; Park SN
    Life Sci; 2017 Dec; 191():52-58. PubMed ID: 28993145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways.
    Shimoda H; Shan SJ; Tanaka J; Maoka T
    J Pharm Pharmacol; 2012 Aug; 64(8):1165-76. PubMed ID: 22775220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethyl Itaconate Reduces α-MSH-Induced Pigmentation via Modulation of AKT and p38 MAPK Signaling Pathways in B16F10 Mouse Melanoma Cells.
    Jang S; Chi WJ; Kim SY
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calycosin, a Common Dietary Isoflavonoid, Suppresses Melanogenesis through the Downregulation of PKA/CREB and p38 MAPK Signaling Pathways.
    Wu KC; Hseu YC; Shih YC; Sivakumar G; Syu JT; Chen GL; Lu MT; Chu PC
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeic acid phenethyl ester inhibits alpha-melanocyte stimulating hormone-induced melanin synthesis through suppressing transactivation activity of microphthalmia-associated transcription factor.
    Lee JY; Choi HJ; Chung TW; Kim CH; Jeong HS; Ha KT
    J Nat Prod; 2013 Aug; 76(8):1399-405. PubMed ID: 23876066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMILE Downregulation during Melanogenesis Induces MITF Transcription in B16F10 Cells.
    Truong XT; Lee YS; Nguyen TTP; Kim HJ; Kim SH; Moon C; Kim DK; Choi HS; Jeon TI
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of saucerneol D on melanin production in cAMP-elevated melanocytes.
    Yun JY; Roh E; Son JK; Lee SH; Seo CS; Hwang BY; Han SB; Kim Y
    Arch Pharm Res; 2011 Aug; 34(8):1339-45. PubMed ID: 21910056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Rottlerin for Skin Hyperpigmentary Disorders by Inhibiting the Transcriptional Activity of CREB-Regulated Transcription Coactivators.
    Kim YH; Kim D; Hong AR; Kim JH; Yoo H; Kim J; Kim I; Kang SW; Chang SE; Song Y
    J Invest Dermatol; 2019 Nov; 139(11):2359-2367.e2. PubMed ID: 31176710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.